Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 9,566,900 | 0 | 7,696,900 | 6,508,820 | 5,637,920 |
| Cost of Goods | 1,955,030 | N/A | 1,801,910 | 1,610,280 | 1,532,550 |
| Gross Profit | 7,611,870 | 6,982,460 | 5,894,990 | 4,898,540 | 4,105,360 |
| Operating Expenses | 4,942,680 | 1,547,630 | 4,309,630 | 3,412,520 | 2,822,510 |
| Operating Income | 2,669,220 | -1,547,630 | 1,586,270 | 1,486,300 | 1,283,410 |
| Other Income | -49,270 | 0 | 432,390 | 53,250 | 91,660 |
| Pre-tax Income | 2,619,950 | -1,547,630 | 2,018,660 | 1,539,550 | 1,375,070 |
| Income Tax | 603,100 | N/A | 450,610 | 455,610 | 395,790 |
| Net Income Continuous | 2,013,616 | 1,900,065 | 1,568,048 | 1,085,000 | 978,000 |
| Net Income | $2,016,840 | $1,900,065 | $1,568,040 | $1,083,930 | $979,280 |
| EPS Basic Total Ops | 0.34 | 0.31 | 0.25 | 0.17 | 0.15 |
| EPS Basic Continuous Ops | 0.34 | 0.31 | 0.25 | 0.17 | 0.15 |
| EPS Diluted Total Ops | 0.33 | 0.31 | 0.25 | 0.17 | 0.15 |
| EPS Diluted Continuous Ops | 0.34 | 0.31 | 0.25 | 0.17 | 0.15 |
| EBITDA(a) | $3,147,020 | $-1,066,560 | $2,139,550 | $1,846,150 | $1,605,720 |